September 14, 1999
 
 
 

                   Some E*Trade Customers
                   To Gain Access to Start-Ups

                   By REBECCA BUCKMAN
                   Staff Reporter of THE WALL STREET JOURNAL

                   First, online investors got a crack at hot initial public stock offerings. Now,
                   a small number of wealthy customers at E*Trade Group could get their
                   hands on even riskier investments: early-stage companies in search of
                   venture capital.

                   E*Trade, of Menlo Park, Calif., said Monday that it had formed a
                   strategic alliance with Garage.com, a Palo Alto, Calif., company that uses
                   the Internet to connect qualified investors with fledgling start-up firms in
                   need of funding.

                   Though only very sophisticated, wealthy
                   investors would likely be eligible to participate,
                   said Tom Bevilacqua, E*Trade's executive
                   vice president for corporate development and strategic investments,
                   E*Trade is "actively working to develop programs whereby our customers
                   would have access to [Garage.com's] originated deals."

                   So far this year, Garage.com says it has helped 20 start-ups raise about
                   $60 million from venture-capital outfits, "angel" investors and corporations.

                   Garage.com screens business plans and posts information about the best
                   ones on its Web site (www.garage.com), allowing investors -- who have
                   paid a fee to participate -- to get in on the action.

                   Mr. Bevilacqua acknowledged that the vast majority of E*Trade investors
                   wouldn't qualify to participate, but said "more than a couple of hundred"
                   could be eligible. And "from a regulatory standpoint, we've got some work
                   to do," since securities regulators have strict rules about who can invest in
                   such speculative deals, he added.

                   By sitting on Garage.com's board and becoming involved in its operations,
                   E*Trade will also get an early look at new companies using cutting-edge
                   technology that E*Trade might use in its own business, Mr. Bevilacqua
                   said.

                   E*Trade led a $12 million round of financing for Garage.com, contributing
                   about half the funding, said Mr. Bevilacqua. Under terms of the deal,
                   E*Trade will take a stake of 5% to 10% in Garage.com and Mr.
                   Bevilacqua will join the company's board.

                   The other investors in the Garage.com financing are Mayfield Fund; Credit
                   Suisse Group's Credit Suisse First Boston Technology Group; and
                   Advanced Technology Ventures, Garage.com said. Garage.com was
                   founded two years ago by former Apple Computer executive Guy
                   Kawasaki.

                   Monday's Market Activity

                   Small-capitalization stocks were moderately lower, while Nasdaq stocks
                   gave up a substantial portion of the gains registered Friday, when the
                   Nasdaq Composite Index climbed to its highest point since July 16.

                                               The Russell 2000 index of
                                               small-capitalization stocks fell 1.54,
                                               or 0.35%, to 439.65, and the
                                               Nasdaq Composite Index, at
                                               2844.77, tumbled 42.29, or 1.46%.

                                               Synaptic Pharmaceutical plunged 3
                                               1/16, or 34%, to 5 7/8. The
                                               Paramus, N.J., biotechnology
                                               company said Merck has stopped
                                               testing an oral drug for a prostate
                                               condition that is based on Synaptic's
                   receptor technology. Prudential Securities lowered its rating on Synaptic to
                   hold from strong buy.

                   TheStreet.com, a New York Internet financial-news company, leapt 5
                   15/16, or 30%, to 25 11/16 following news that the company plans to
                   launch a Web site aimed at the financial markets in Britain, and that it
                   received venture-capital funding from investors such as Chase Capital
                   Partners, Barclay's Private Equity, ETF Group and 3i Group.

                   Incyte Pharmaceuticals, a Palo Alto, Calif., developer of database
                   products containing information on human genes, plummeted 14 1/8, or
                   34%, to 27 1/4. The company late Friday said the U.S. Patent Office
                   made a patent-dispute finding that favored Affymetrix over Incyte. Incyte
                   said it will appeal the decision. ING Barings and Warburg Dillon Read
                   Monday lowered their ratings on Incyte.

                   ESG Re, a Bermuda reinsurance provider, tumbled 2 15/16, or 23%, to a
                   52-week low of 9 15/16. The company late Friday said its chief executive
                   resigned. Donaldson Lufkin & Jenrette Securities and Advest Monday
                   both lowered their ratings on ESG to market perform from buy.

                   Computer Task Group slid 1 5/8, or 9.7%, to a 52-week low of 15 3/16
                   on the New York Stock Exhange after the Buffalo, N.Y.,
                   technology-services company said revenue and earnings for the remainder
                   of the year will be below analysts' expectations, citing an industrywide
                   reduction in information-technology spending.

                   PairGain Technologies slipped 11/16, or 5.3%, to 12 3/16 after the Tustin,
                   Calif., maker of digital-telecommunications products said third-quarter
                   revenue and operating earnings will fall "well below current market
                   expectations."

                   Hoover's, an Austin, Texas, publisher of business information that gets
                   distributed on the Internet, surged 5 5/8, or 50%, to 16 7/8. A J.P.
                   Morgan analyst issued a positive note about Hoover's, saying the company
                   will officially launch a revamped edition of its Web site
                   (www.hoovers.com) on Wednesday, and that it will launch a major
                   television and print advertising campaign next week.

                   Leap Wireless International shot up by 5 13/16, or 40%, to 20 1/2.
                   Morgan Stanley Dean Witter initiated coverage of the San Diego
                   telecommunications company with a rating of outperform and set a
                   year-end 2000 price target of $30.

                   Sound Advice jumped 1 3/4, or 22%, to a 52-week high of 9 3/4. The
                   Dania, Fla., entertainment and consumer-electronics retailer posted a
                   second-quarter profit of 21 cents a share, reversing its year-earlier six-cent
                   loss.

                   Maxim Pharmaceuticals, a San Diego drug developer, climbed 1 1/4, or
                   16%, to 9 3/16 on the American Stock Exchange. Maxim said its
                   preclinical tests of combination therapy with Maxamine (histamine) and
                   interleukin-2 resulted in reduction and killing of cancer cells in rats with
                   prostate-cancer tumors.

                   Write to Larry Bauman at larry.bauman@dowjones.com
 

                   Want to receive a daily e-mail roundup of trading in stocks, bonds and
                   foreign exchange? See the E-Mail Setup page for details on how to
                   subscribe.
 
 
 
 

                                Return to top of page